MMitraTender

Lamivudine Tablet: GeM business opportunity

Who buys Lamivudine Tablet on GeM, in which states, how many sellers compete and what wins. Change the filters to match your business.

Live bids: 1Awarded results: 0Live tenders →

What can you do?

GeM categoryLamivudine Tablet
About your business

Live bids + bids closed 2025-11-07 – 2026-11-07 (365 days). Includes imported GeM history.

Live bids
1
Closed in period
4
Awarded results
0
Median winning price (L1)
—
Avg bidders per bid
—

Tenders published per month

Last 12 months, matching your filters

0 Dec 2025
0 Jan 2026
0 Feb 2026
11 Mar 2026
0 Apr 2026
1 May 2026
0 Jun 2026
0 Jul 2026
0 Aug 2026
1 Sept 2026
1 Oct 2026
1 Nov 2026
Show as table
MonthTenders
Dec 20250
Jan 20260
Feb 20260
Mar 20261
Apr 20260
May 20261
Jun 20260
Jul 20260
Aug 20260
Sept 20261
Oct 20261
Nov 20261

How open are these bids?

No EMD needed
100%

based on 1 bids

MSE turnover/experience relaxed
100%

based on 1 bids

Reverse auction
25%

based on 4 bids

Turnover, experience, EMD and exemptions come from bid documents and are still sparse; every share shows how many bids it is based on. Results improve as more history is imported.

Top 10: where to work

Ranked by opportunity score (0–100). Open a row to see why.

  1. 1
    Lamivudine Tablet65/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    100
    Momentum
    50
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  2. 2
    Entecavir Tablet57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    77
    Momentum
    42
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  3. 3
    Bicalutamide Tablets (V2)57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  4. 4
    Ondansetron Injection57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  5. 5
    Ipratropium Bromide Respules (V2)57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  6. 6
    Brimonidine Tartrate + Timolol Maleate Drops (V2)57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  7. 7
    Brimonidine Drops (V2)57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  8. 8
    Erythropoietin Injection57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  9. 9
    Clobazam Tablets (V2)57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  10. 10
    Metoprolol Tablet56/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    61
    Momentum
    63
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
Show as table
RankNameScoreLive bidsClosed in periodAvg bidders per bidMedian winning price (L1)
1Lamivudine Tablet6514——
2Entecavir Tablet5712——
3Bicalutamide Tablets (V2)5710——
4Ondansetron Injection5710——
5Ipratropium Bromide Respules (V2)5710——
6Brimonidine Tartrate + Timolol Maleate Drops (V2)5710——
7Brimonidine Drops (V2)5710——
8Erythropoietin Injection5710——
9Clobazam Tablets (V2)5710——
10Metoprolol Tablet5611——
How the opportunity score works

Score = Volume 30% + Momentum 20% + Low competition 25% + Easy criteria 15% + Order value 10%. Each part is 0–100; a part without enough data counts as a neutral 50.

  • Volume: tenders in the period, compared with the biggest row of the list.
  • Momentum: share published in the last 30 days vs the average (100 = twice as fast).
  • Low competition: 2 bidders per bid = 100, 15 or more = 0.
  • Easy criteria: share of read bid documents with no EMD, an MSE/startup exemption or no turnover/experience criterion.
  • Order value: median winning (L1) price, compared with the highest in the list.

Who wins these bids

Top L1 sellers in awarded bids of the period

No awarded results for these filters yet.

AI business advisor

Get a short plan from these numbers: where to start, whom to sell to, what to prepare and the risks.

Lamivudine Tablet on GeM: Buyers, Competition & Winning Prices | Mitra Tender